|
Mahmoud B. Malas, MD, MHS
Back To Last Session:  Print Faculty Schedule:
 |
|
San Diego, California
 Professor of Surgery and Epidemiology
University of California San Diego, Johns Hopkins Bloomberg School of Public Health
Chief, Vascular and Endovascular Surgery
University of California San Diego
|
| SCHEDULE FOR VEITHsymposium™ |
| Thursday, November 21, 2019 |
|
Presenter
Advantages Of The Relay Plus Endograft For TEVAR: Why Does It Have A Lower Stroke Rate Than Other TEVAR Devices
10:52 AM - 10:57 AM
|
| Friday, November 22, 2019 |
|
Presenter
TCAR Outcomes Compare Favorably With Those Of CEA Even In Symptomatic Medically High Risk Patients: A Propensity Matched Study Of 5160 Patients From The SVS VQI Registry
8:42 AM - 8:47 AM
|
|
Presenter
DEBATE: Not So: TCAR Is Safer Than Transfemoral CAS Especially In Older (> 77) High Risk Patients With High Risk Lesions: TCAR Should Be The Standard Of Care For Invasive Treatment
8:54 AM - 8:59 AM
|
| Saturday, November 23, 2019 |
|
Presenter
What Are The Real Differences Between Open And Closed Cell Stents For CAS: When Are Closed Cell Stents Worse: From SVS VQI Data
12:10 PM - 12:15 PM
|
|
Presenter
When And Why Should Direct Carotid Access Stenting (TCAR) Replace CEA And Transfemoral CAS: When Should It Not
12:21 PM - 12:31 PM
|
| previous | next |